The exploration and analysis of the CRLF2 expression level and molecular types of B-ALL revealed that the molecular types were heterogeneous in patients with different CRLF2 expression levels. This evidence concerns the gene CRLF2 and precursor B-cell acute lymphoblastic leukemia.